Highlights include: a memorandum of understanding with Memorial Sloan Kettering Cancer Center and a novel new partnership with Boundless Bio, a next-generation precision oncology company
SOPHiA GENETICS next-generation solution CarePath, fueled by current real world observational data, was previewed for attendees
BOSTON and GENEVA, Switzerland, Sept. 21, 2022 (GLOBE NEWSWIRE) -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company in the healthcare space, hosted its first-ever Investor Day on Tuesday, September 20, 2022, in New York City.
The event, hosted by the CEO and Co-Founder Dr. Jurgi Camblong and members of the executive leadership team, provided a roadmap of the Companys long-term vision and highlighted new commercial opportunities and partnerships. One takeaway from the event was SOPHiA GENETICS acceleration into the Biopharma space, which opens the door for new opportunities for market growth. The audience also heard how the Companys strategic business model allows for it to continue to provide robust depth in the clinical space.
A key theme throughout the day was how we innovate; how SOPHiA GENETICS, from its inception, has identified opportunities in the healthcare industry for innovation and acceleration of data sharing to advance medicine, research and patient care, said Jurgi Camblong, CEO and Co-Founder, SOPHiA GENETICS. Our vision is made possible by the strong foundation our company has been built on, as well as the strategic relationships we have formed to further our mission of democratizing data-driven medicine.
New Collaboration with One of the Top-Ranked Cancer Centers in the United StatesSOPHiA GENETICS recently announced a memorandum of understanding to enter into a collaboration with Memorial Sloan Kettering Cancer Center (MSK). Once executed, the collaboration agreements will blend the power of SOPHiA GENETICS large, global network and deep expertise in predictive algorithms with MSKs clinical expertise in cancer genomics. The collaboration agreements will also allow SOPHiA GENETICS global network of healthcare providers access to MSKs proprietary tumor sequencing tests such as MSK-IMPACT, for analyzing tumors. Additionally, the collaboration agreements will combine MSKs rich precision oncology data with the SOPHiA CarePathmodule to enable the acceleration of actionable insights from data to improve patient outcomes.
Our vision is to expand access to world-class data, including to our current network, which contributes to the collective intelligence of the SOPHiA GENETICS platform, said Philippe Menu, M.D.-Ph.D., Chief Medical Officer, SOPHiA GENETICS.
Enabling Biotech Developing Novel Cancer Therapies Targeting Oncogene AmplificationSOPHiA GENETICS announced a partnership with Boundless Bio, a next-generation precision oncology company developing innovative therapeutics directed against extrachromosomal DNA (ecDNA) in oncogene amplified cancers.
It has been well established that patients with oncogene amplification generally do not benefit from standard of care cancer treatments, and unlike other forms of oncogenic gene alterations, oncogene amplification frequently occurs on ecDNA. ecDNA are circular units of nuclear DNA that are distinct from normal chromosomes and are the primary site for high copy number amplification in cancer. Boundless Bio is developing the first ecDNA-directed therapies (ecDTx) along with a precision diagnostic method called ECHO (ecDNA Harboring Oncogenes) to detect ecDNA from a patients routine tumor sequencing data.
The partnership between Boundless Bio and SOPHiA GENETICS will further develop ECHO for use in ecDTx clinical trials.
SOPHiA GENETICS unique ability to harmonize data derived from diverse genomic instruments and deploy as a robust, standardized solution enables a new model for clinical trial testing. This decentralized, global genomic solution combined with Boundless Bios ecDTx drug development capabilities aims to unlock value by breaking the barriers inherent to the traditional central lab approach; optimizing patient selection and clinical trial design; and enabling a global collective network of major hospitals and academic centers to effectively deliver new treatment options to patients with oncogene amplified cancers.
We are pleased to partner with SOPHiA GENETICS for the development of Boundless Bios ecDNA detection algorithm, ECHO, into a clinical trial device, said Peter Krein, Ph.D., Vice President of Precision Medicine at Boundless Bio. The ability to identify patients with ecDNA driven tumors is critical to our mission in addressing this area of high unmet medical need. SOPHiA GENETICS unique expertise in developing cloud based IVD NGS software algorithms makes them an ideal partner to develop ECHO into an investigational device.
DEEP-Lung-IV Multimodal Clinical Study Fuels New SOPHiA Carepath PlatformIn late 2021, SOPHiA GENETICS launched a DEEP-Lung-IV Multimodal Clinical Study with the goal of aggregating real-world multimodal (genomic, clinical, biological and radiomic) data for patients with metastatic non-small cell lung cancer. The study has garnered interest from top-tier centers globally, with a strong patient recruitment trend; to-date, nearly 900 patients across 23 sites have been enrolled in the study. As patients have been followed along the patient journey, data sets have been collected and analyzed by SOPHiA GENETICS machine learning algorithm to predict how the patients will respond to immunotherapy and why.
These robust and growing patient data will inform SOPHiA GENETICS artificial intelligence and machine learning that will fuel the forthcoming SOPHiA CarePathmodule, a new product that will be launched on the SOPHiA DDM Platform and aims to be the vehicle healthcare practitioners can use to leverage the real-world, real-time insights obtained from this study. The SOPHiA CarePathmodule will provide the following benefits:
Alongside these announcements, a full recording of the event is available on theInvestor Relationspage of the companys website.
About SOPHiA GENETICSSOPHiA GENETICS (Nasdaq: SOPH) is a software company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It is the creator of the SOPHiA DDM Platform, a cloud-native platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The SOPHiA DDM Platform and related solutions, products and services are currently used by a broad network of hospital, laboratory, and biopharma institutions globally. For more information, visitSOPHiAGENETICS.COM, or connect onTwitter,LinkedIn, Facebook, andInstagram.Where others see data, we see answers
SOPHiA GENETICS products are for Research Use Only and not for use in diagnostic procedures, unless specified otherwise. The information in this press release is about products that may or may not be available in different countries and, if applicable, may or may not have received approval or market clearance by a governmental regulatory body for different indications for use. Please contact support@sophiagenetics.com to obtain the appropriate product information for your country of residence.
SOPHiA GENETICS Forward-Looking Statements:This press release contains statements that constitute forward-looking statements. All statements other than statements of historical facts contained in this press release, including statements regarding our future results of operations and financial position, business strategy, products and technology, as well as plans and objectives of management for future operations, are forward-looking statements. Forward-looking statements are based on our managements beliefs and assumptions and on information currently available to our management. Such statements are subject to risks and uncertainties, and actual results may differ materially from those expressed or implied in the forward-looking statements due to various factors, including those described in our filings with the U.S. Securities and Exchange Commission. No assurance can be given that such future results will be achieved. Such forward-looking statements contained in this press release speak only as of the date hereof. We expressly disclaim any obligation or undertaking to update these forward-looking statements contained in this press release to reflect any change in our expectations or any change in events, conditions, or circumstances on which such statements are based, unless required to do so by applicable law. No representations or warranties (expressed or implied) are made about the accuracy of any such forward-looking statements.
Media Contact:Kelly KatapodisSenior Manager, Media & Communicationsmedia@sophiagenetics.com
Investor Contact:Jennifer PottageHead of Investor Relationsir@sophiagenetics.com
View original post here:
SOPHiA GENETICS Unveils Strategy to Drive Health Care Innovations at Inaugural Investor Day Event - GlobeNewswire
- Could Genetics Influence Cancer Risk From Red and Processed Meats? - Technology Networks - March 19th, 2024
- Genetics of environmental sensitivity and its association with variations in emotional problems, autistic traits, and ... - Nature.com - March 19th, 2024
- The Global Parkinson's Genetics Program and Psomagen Inc. Make Agreement with Goal to Transform Parkinson's ... - PR Newswire - March 19th, 2024
- SOPHiA GENETICS and The French Kidney Cancer Research Network (UroCCR) Publish Results from Multiyear ... - Yahoo Finance - March 19th, 2024
- Mindfulness in your DNA? Capacity to be present is partly a function of genetics, study finds - PsyPost - March 19th, 2024
- Are your cattle genetics protected from the lab-grown meat industry? - Agweek - January 23rd, 2024
- AI Harnesses Tumor Genetics to Predict Treatment Response - University of California San Diego - January 23rd, 2024
- The Role of Genetics in Cancer Care Continues to Expand - OncLive - January 23rd, 2024
- Jeremy Allen White's Plush Pout Is Thanks to Genetics and This $20 Lip Salve - InStyle - January 23rd, 2024
- Seed Experimentation and Genetics Videos Mother Earth News - Mother Earth News - January 23rd, 2024
- Kansas professor highlights role of genetics in the sustainable cow herd - Canadian Cattlemen - January 23rd, 2024
- Raha Kapoor's blue eyes remind fans of her great-grandfather, Raj Kapoor; here's what genetics says - IndiaTimes - December 29th, 2023
- Cell perturbation and lasers illuminate the genetics of latent blood cell traits - Nature.com - December 29th, 2023
- BASIC GENETICS INFORMATION - Understanding Genetics - NCBI Bookshelf - December 20th, 2023
- What is Genetics? | AMNH - American Museum of Natural History - December 20th, 2023
- Genetics of host plants determine what microorganisms they attract, finds study - Phys.org - December 20th, 2023
- Perception of genomic newborn screening among peripartum mothers | European Journal of Human Genetics - Nature.com - December 20th, 2023
- Growing Cotton in Space: How breakthroughs in plant genetics could lead to more resilient crops on Earth - RFD-TV - December 20th, 2023
- Study sheds light on the ancestry and genetics of Coast Salish woolly dogs | News | Vancouver Island University ... - Vancouver Island University News - December 20th, 2023
- Early bird, night owl behavior influenced by genetics, lead to varying levels of productivity - The Campanile - December 20th, 2023
- Psoriasis: Whats the Genetic Link? - Healthline - December 27th, 2022
- Healthline: Medical information and health advice you can trust. - December 27th, 2022
- Deep Dive Ties Together Dog Genetics, Brain Physiology and Behavior to Explain Why Collies Are Different from Terriers - Scientific American - December 10th, 2022
- Genetics - breast cancer - October 29th, 2022
- JK Agri Genetics reports standalone net loss of Rs 15.77 crore in the September 2022 quarter - Business Standard - October 21st, 2022
- Age Vs. Genetics: Which Is More Important For How You Age? - Patch - October 13th, 2022
- Global Animal Genetics Market is estimated to garner a revenue of ~USD 10067 Million by the end of 2033; Growing Prevalence of Animal Infectious... - October 13th, 2022
- Influence of the microbiome, diet and genetics on inter-individual variation in the human plasma metabolome - Nature.com - October 13th, 2022
- ASHG 2022 in Los Angeles brings together researchers from around the world to advance discoveries in genetics, genomics research - EurekAlert - October 13th, 2022
- Those who invested in Fulgent Genetics (NASDAQ:FLGT) five years ago are up 833% - Yahoo Finance - October 13th, 2022
- Global Biobank Meta-analysis Initiative making genome-wide association studies more diverse and representative - EurekAlert - October 13th, 2022
- Optimal for His Genetics Legendary Bodybuilder Ronnie Coleman Once Got His Genes Tested and Received Interesting Results - EssentiallySports - October 13th, 2022
- Breast Cancer Awareness | Surgeons see increase of genetic instances of disease - Meadville Tribune - October 13th, 2022
- About Bad Chest Genetics, and Whether You Can Fix Them - Healthline - October 4th, 2022
- Tissue-specific impacts of aging and genetics on gene expression patterns in humans - Nature.com - October 4th, 2022
- Genetics of human evolution wins 2022 Nobel Prize in physiology or medicine - Science News Magazine - October 4th, 2022
- Stroke genetics informs drug discovery and risk prediction across ancestries - Nature.com - October 4th, 2022
- Illumina aims to push genetics beyond the lab with $200 genome - The Spokesman Review - October 4th, 2022
- $2.6M DOE Grant Supports UMD-led Study on Genetics of Plant Growth - Maryland Today - October 4th, 2022
- Are Kinks Hereditary? What Science Says About the Genetics of Desire - Glamour - October 4th, 2022
- Study on rare genetic diseases among diverse demographics in India - The Hindu - October 4th, 2022
- Howard University's Office of Research Awarded $11.5 Million From Chan Zuckerberg Initiative To Advance Genomics And Genetics Research - The Dig - October 4th, 2022
- CENTOGENE Reaches 12,500 Patient Milestone in Worlds Largest Observational Study on Parkinsons Disease Genetics - Yahoo Finance - October 4th, 2022
- The real power ofimproved genetics - Farming Life - October 4th, 2022
- CIA Just Invested In Woolly Mammoth Resurrection Tech - The Intercept - October 4th, 2022
- Fighting the Monkeypox Virus: Genetics as a Predictor of Vaccinia Vaccine Effectiveness - Medical News Bulletin - October 4th, 2022
- Improved pea reference genome and pan-genome highlight genomic features and evolutionary characteristics - Nature.com - September 25th, 2022
- TU Researchers connect genetic ancestry with prostate tumors - Tuskegee University - September 25th, 2022
- Large-scale and small-scale population genetic structure of the medically important gastropod species Bulinus truncatus (Gastropoda, Heterobranchia) -... - September 25th, 2022
- Purrsonalised health: The startups and VCs betting on pet genetics - Sifted - September 16th, 2022
- Uncovering the genetic basis of mental illness requires data and tools that aren't just based on white people - Down To Earth Magazine - September 16th, 2022
- Solving medical mysteries with genetics: The Penn Neurogenetics Therapy Center | Penn Today - Penn Today - September 16th, 2022
- CHOPs new bird-proofed skyscraper will focus on vaccine and genetics research - The Philadelphia Inquirer - September 16th, 2022
- Leading Clinical Experts Across the U.S. Unite to Support Universal Genetic Testing for all Patients with Cancer - PR Newswire - September 16th, 2022
- Preimplantation Genetic Testing Market: Growing Demand for Genetically Testing and Rising Knowledge of Genetics to Drive the Market - BioSpace - September 16th, 2022
- People with ME invited to take part in major genetic study - The Independent - September 16th, 2022
- Can genetics breathe new life into giant river prawn production? - The Fish Site - September 16th, 2022
- Hybrid genetics is the future of UK beef, legendary US rancher says - FarmingUK - September 16th, 2022
- How geneticists can gain greater buy-in from the autistic community - Spectrum - September 16th, 2022
- Ancient Viking poop helped scientists map the genetics of a 5000-year-old parasite - Interesting Engineering - September 8th, 2022
- Project Uses OpenCDS, Chatbots to Broaden Genetic Testing's Reach - Healthcare Innovation - September 8th, 2022
- The power of genetics to unleash the potential of indoor farming - Vertical Farm Daily - September 8th, 2022
- Social Determinants and Genetics Work in Tandem to Drive Disparities in Breast Cancer Care - OncLive - September 8th, 2022
- Ticking away in the back of my mind: what does it mean to know the risk embedded in your DNA? - The Guardian - September 8th, 2022
- How are genetic technologies being applied to combat infectious diseases in aquaculture? - The Fish Site - September 8th, 2022
- CCMB zeroes in on major genetic causes of male infertility - The Hans India - September 8th, 2022
- In Brief This Week: Illumina, Interpace, Genetic Signatures, Guardant Health, More - GenomeWeb - September 8th, 2022
- Atossa Genetics (ATOS) Atossa Therapeutics, Inc. to Attend the 24th Annual H.C. Wainwright Global Inves - Benzinga - September 8th, 2022
- Genetics - National Institute of General Medical Sciences (NIGMS) - August 30th, 2022
- The genetics behind why some people get sicker with COVID-19 than others - ABC News - August 30th, 2022
- Ambry Genetics Publishes 43,000 Patient Study Showing Combined RNA and DNA Analysis Identifies Patients Who Are High-Risk for Cancer but Would Have... - August 30th, 2022
- Is COVID-19 Loss of Smell Genetic? What Research Shows - Healthline - August 30th, 2022
- Principal Component Analyses (PCA)-based findings in population genetic studies are highly biased and must be reevaluated | Scientific Reports -... - August 30th, 2022
- You're in control: Exercise outweighs genetics when it comes to longer life - Study Finds - August 30th, 2022
- An international team sets out to cure genetic heart diseases with one shot - Freethink - August 30th, 2022
- Olufunmilayo I. Olopade, MD: Cutting Into Breast Cancer Disparities With Genetic Testing - Everyday Health - August 30th, 2022
- Yale Study Suggests That Evolution Can Be Predicted - SciTechDaily - August 30th, 2022
- Could Genetics Be the Key to Never Getting the Coronavirus? - The Atlantic - July 27th, 2022
- Noonan appointed Kent Professor of Genetics and Professor of Neuroscience - Yale News - July 27th, 2022
- Happy 200th birthday, Gregor Mendel: 5 ways the father of modern genetics impacted your life today - Clemson News - July 27th, 2022